INCY has been granted a new patent
Feb 12, 2025, 11:32 PM
-2.01%
What does INCY do
Yte is a Wilmington, Delaware-based biopharmaceutical company with 2,524 employees, focusing on hematology/oncology and inflammation/autoimmunity therapeutic areas. Its product portfolio includes JAKAFI, MONJUVI, and PEMAZYRE, among others.
INCY filed a patent for "methods of treating chronic graft-versus-host disease using an anti-colony stimulating factor 1 receptor antibody" on Sun, July 23, 2023.
📡️ Health Care
Patents
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.